Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department

Clinical Biochemistry

Volumn 47, Issue 7-8, 2014, Pages 505-508

  Romualdo, Luis García de Guadiana ^a,b   Torrella, Patricia Esteban ^a,b   González, Monserrat Viqueira ^a,b   Sánchez, Roberto Jiménez ^a,b   Holgado, Ana Hernando ^a,b   Freire, Alejandro Ortín ^a,b   Acebes, Sergio Rebollo ^a,b   Otón, María Dolores Albaladejo ^a,b  

^a University Hospital Santa Lucía   (Spain)

^b Microbiology Department University Hospital Santa Lucía ^*  (Spain)

Author keywords

Bacteremia; C reactive protein; Diagnostic accuracy; Emergency department; Presepsin; Procalcitonin; SIRS

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; GLYCOPROTEIN; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG;

AGED; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BLOOD CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ADULT; EMERGENCY HEALTH SERVICE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; AREA UNDER CURVE; BACTEREMIA; C-REACTIVE PROTEIN; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84900327375     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.02.011     Document Type: Article

References (26)

1. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
2. Lodise T.P., Mc Kinnon P.S., Swiderski L., Rybak M.J. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003, 36:1418-1423.
3. Lodise T.P., Patel J.R., Kwa A., Graves J., Furuno J.P., Graffunder E., et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007, 51:3510-3515.
4. Tokuda Y., Miyasato H., Stein G.H. A simple prediction algorithm for bacteremia in patients with acute febrile illness. Q J Med 2005, 98:813-820.
5. González Castillo J., Candel F.J., Julián-Jiménez A. Antibióticos y el factor tiempo en la infección en urgencias. Enferm Infecc Microbiol Clin 2013, 31:173-180.
6. Tudela P., Lacoma A., Prat C., Modol J.M., Giménez M., Barallat J., et al. Predicción de bacteriemia en los pacientes con sospecha de infección en urgencias. Med Clin (Barc) 2010, 15:685-690.
7. Riedel S., Meléndez J., An A., Rosebaum J., Zenilman J. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011, 135:182-189.
8. Julián-Jiménez A., Candel-González F.J., González del Castillo J. Utilidad de los biomarcadores de inflamación e infección en los servicios de urgencias. Enferm Infecc Microbiol Clin 2013, 10.1016/j.eimc.2013.01.005.
9. Chirouze C., Schuhmacher H., Rabaud C., Gil H., Khayat N., Estavoyer J.M., et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adults patients with acute fever. Clin Infect Dis 2002, 35:156-161.
10. Tromp M., Lansdorp B., Bleeker-Rovers C.P., Klein J.M., Kullberg B.J., Pickkers P. Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement. J Infect 2012, 65:292-301.
11. Jeong S., Park Y., Cho Y., Kim H.S. Diagnostic utilities of procalcitonin and C-reactive protein for the prediction of bacteremia determined by blood culture. Clin Chim Acta 2012, 413:1731-1736.
12. Jones A.E., Fiechtl J.F., Brown M.D., Ballew J.J., Kline J.A. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007, 50:34-41.
13. Schneider H.G., Lam Q.T. Procalcitonin for the clinical laboratory: a review. Pathology 2007, 38:383-390.
14. Bas S., Gauthier B., Spenato U., Stingelin S., Gabay C. CD14 is an acute-phase protein. J Immunol 2004, 172:4470-4479.
15. Mussap M., Noto A., Fravega M., Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):12-14.
16. Shozushima T., Takahashi G., Matsumoto N., Kojika M., Okamura Y., Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of systemic inflammatory response syndrome. J Infect Chemother 2011, 17:764-769.
17. Endo S., Suzuki Y., Takahashi G., Shozushima T., Ishikura H., Murai M., et al. Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. J Infect Chemother 2012, 18:891-897.
18. Spanuth E., Ivandic B., Ivandic B., Ebelt H., Werdan K. The new sepsis marker presepsin is superior for prognosis and disease monitoring compared to procalcitonin. Biochim Clin 2013, 37:S150.
19. Ulla M., Pizzolato E., Lucchiari M., Loiacono M., Soardo F., Forno D., et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicentre prospective study. Crit Care 2013, 17:R168.
20. Liu B., Chen Y.X., Yin Q., Zhao Y.Z., Li C.S. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit Care 2013, 17:R244.
21. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus A.M., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
22. Cisneros J.M., Cobo J., Pujol M., Rodríguez J., Salavert M. Guía para el diagnóstico y tratamiento del paciente con bacteriemia. Guías Clínicas SEIMC 2006 2006, [[consulted 6/2013]. Available in www.seimc.org/documentoscientíficos/guíasclínicasseimc]. J.M. Aguado, J. Fortún (Eds.).
23. Matera G., Puccio R., Giancotti A., Quirino A., Pulicari M.C., Zicca E., et al. Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study. Crit Care 2013, 17:R64. [Epub ahead of print].
24. Hoenigl M., Raggam R., Wagner J., Valentin T., Leitner E., Seeber K., et al. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome. Clin Biochem 2013, 46:225-229.
25. Kung C.T., Hsiao S.Y., Su C.M., Tsai T.S., Cheng H.H., Tsai N.W., et al. Serum adhesion molecules as predictors of bacteremia in adult severe sepsis patients at the emergency department. Clin Chim Acta 2013, 421:116-120.
26. Okamura Y., Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 2011, 412:2157-2161.